currency

Graham

Pharma

With Polivy beat, Roche fleshes out blood cancer ambitions

Roche now expects its antibody-drug conjugate Polivy to take over roughly 65% of the market in front-line diffuse large B-cell lymphoma.

Angus Liu Oct 19, 2023 11:28am

A stock ticker showing Q3 results

Sanofi, GSK and Novo benefit from currency changes: analyst

Oct 21, 2022 9:21am

dollar sign money

Sanofi says Q3 earnings will be boosted by value of U.S. dollar

Sep 28, 2022 11:24am